+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Candidiasis Drug"

North America Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 71 Pages
  • North America
From
LAMEA Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 82 Pages
  • Middle East, Africa
From
Europe Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Vulvovaginal Candidiasis Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Route of Administration (Oral, Intravenous and Topical), By Drug Class, By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 82 Pages
  • Europe
From
Yeast Infection Market based on Pathogen Type, Infection Type, Treatment, End Users and Geography - Global Forecast up to 2027 - Product Thumbnail Image

Yeast Infection Market based on Pathogen Type, Infection Type, Treatment, End Users and Geography - Global Forecast up to 2027

  • Report
  • July 2021
  • 138 Pages
  • Global
From
Candidiasis Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Candidiasis Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • March 2024
  • 111 Pages
  • Global
From
Vulvovaginal Candidiasis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Vulvovaginal Candidiasis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 81 Pages
  • Global
From
Oropharyngeal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Oropharyngeal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 35 Pages
  • Global
From
Vulvovaginal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Vulvovaginal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 44 Pages
  • Global
From
Systemic Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Systemic Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 55 Pages
  • Global
From
Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 169 Pages
  • Global
From
Bacterial Vaginosis (Infectious Disease) - Drugs in Development, 2021 - Product Thumbnail Image

Bacterial Vaginosis (Infectious Disease) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Candidiasis - Pipeline Review, H2 2020 - Product Thumbnail Image

Candidiasis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 225 Pages
  • Global
From
Loading Indicator

Candidiasis is a type of fungal infection caused by the yeast Candida. It is one of the most common forms of fungal infection and can affect the skin, mucous membranes, and other organs. Treatment for candidiasis typically involves antifungal drugs, such as fluconazole, itraconazole, and amphotericin B. These drugs are used to treat a variety of fungal infections, including those caused by Candida. The Candidiasis Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat fungal infections caused by Candida, such as fluconazole, itraconazole, and amphotericin B. These drugs are used to treat a variety of fungal infections, including those caused by Candida. Some companies in the Candidiasis Drug market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more